The nanoparticles "hold immense potential to be promoted as an antiplatelet agent," the researchers note.
研究者们指出“纳米粒子是一种极具潜力的抗血小板聚集制剂”。
Aspirin remains the only antiplatelet agent for which data support use in acute stroke, although trials with other agents are in progress.
阿司匹林还是唯一的一个有证据支持其在急性脑卒中使用的抗血小板药。其它的药物还在试验中。
This article mainly discusses the clinical application and optimal dosage of the antiplatelet agent and its combination with other interventions.
文章主要探讨抗血小板药的临床应用、最佳剂量以及抗血小板药与其他干预手段的联合应用。
应用推荐